Early skin disease drug trial halted
Disease control
Terminated
This early-stage study aimed to test the safety and side effects of a new drug called XmAb27564 in people with plaque psoriasis and atopic dermatitis (eczema). Participants received four injections of either the drug or a placebo over several weeks. The study was terminated early…
Phase: PHASE1 • Sponsor: Xencor, Inc. • Aim: Disease control
Last updated Apr 01, 2026 14:41 UTC